‘Dravet Syndrome – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Dravet Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan
Study Period: 2017–2030
Dravet Syndrome Understanding
The Dravet Syndrome epidemiology report gives a thorough understanding of the Dravet Syndrome by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Dravet Syndrome in the US, Europe, and Japan. The report covers the detailed information of the Dravet Syndrome epidemiology scenario in seven major countries (US, EU5, and Japan).
Dravet Syndrome Epidemiology Perspective
The Dravet Syndrome epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Dravet Syndrome epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Dravet Syndrome epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
The Dravet Syndrome epidemiology covered in the report provides historical as well as forecasted Dravet Syndrome epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
The Dravet Syndrome report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
Scope of the Report • The Dravet Syndrome report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns • The Dravet Syndrome Epidemiology Report and Model provide an overview of the global trends of Dravet Syndrome in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) • The report provides insight into the historical and forecasted patient pool of Dravet Syndrome in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population • The report assesses the disease risk and burden and highlights the unmet needs of Dravet Syndrome
• The report provides the segmentation of the Dravet Syndrome epidemiology
• 11-year Forecast of Dravet Syndrome epidemiology • 7MM Coverage • Incidence and Diagnosed Cases of Dravet Syndrome • Mutation positive cases of Dravet Syndrome • Mutation cases by class and types • Seizure associated cases of Dravet Syndrome • Gender-specific cases of Dravet Syndrome • Age-specific cases of Dravet Syndrome
We interview, KOLs and SME’s opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Key Questions Answered • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Dravet Syndrome? • What are the key findings pertaining to the Dravet Syndrome epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017–2030)? • What would be the total number of patients of Dravet Syndrome across the 7MM during the forecast period (2017–2030)? • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017–2030)? • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017–2030)? • What is the disease risk, burden and unmet needs of Dravet Syndrome? • What are the currently available treatments of Dravet Syndrome?
Reasons to buy • The Dravet Syndrome Epidemiology report will allow the user to - • Develop business strategies by understanding the trends shaping and driving the global Dravet Syndrome market • Quantify patient populations in the global Dravet Syndrome market to improve product design, pricing, and launch plans • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Dravet Syndrome therapeutics in each of the markets covered
• Understand the magnitude of Dravet Syndrome population by its epidemiology • The Dravet Syndrome Epidemiology Model developed is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Key Assessments • Patient Segmentation • Disease Risk & Burden • Risk of disease by the segmentation • Factors driving growth in a specific patient population
Our reports have been used by over 10K customers, including:
Multiple Sclerosis Market Research Report by Treatment Modality (Injectable Agents and Oral Agents), by Application (Hospital and Research) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Multiple Sclerosis Market is expected to grow from USD 12,388.92 Million in 2019 to USD 18,820.19 Million by...
Diabetic Neuropathy Market Research Report by Treatment Type (Drugs, Physiotherapy, and Radiotherapy), by Disorder Type (Autonomic Neuropathy, Focal Neuropathy, Peripheral Neuropathy, and Proximal Neuropathy), by Distribution channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Diabetic Neuropathy...
Myasthenia Gravis Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Myasthenia Gravis Global Clinical Trials Review, H2, 2020" provides an overview of Myasthenia Gravis Clinical trials scenario.This report provides top line data relating to the clinical trials on Myasthenia...
Autism - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Autism - Pipeline Review, H2 2020, provides an overview of the Autism (Central Nervous System) pipeline landscape. Autism, also known as complex developmental disability, is a neurodevelopment...
Restless Legs Syndrome - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Restless Legs Syndrome - Pipeline Review, H2 2020, provides an overview of the Restless Legs Syndrome (Central Nervous System) pipeline landscape. Restless legs syndrome...